Comments on: Pharma Find Patents More Elusive for Stereoisomers

By: mod ibra

mod ibra — Mon, 21 Jan 2008 09:30:52 +0000

i need to know is their actual differences in potenct between 5 s & rrsss mixture kindly comment

By: Pharma Find Patents More Elusive for Stereoisomers — Pharmacy medicine shop

Wed, 07 Nov 2007 18:18:23 +0000

[...] The going has always been tough for getting pharmaceutical patents. The going is getting tougher. See Aventis Pharma Deutschland Gmbh and King Pharmaceuticals, Inc., v. Lupin, Ltd. (06-1530). In a patent infringement action concerning the pharmaceutical compound ramipril, marketed by King as a blood pressure medication under the name Altace, the U.S. Court of Appeals for the Federal Circuit followed the recent Supreme Court guidelines on obviousness and struck down a stereoisomer as obvious. source: Pharma Find Patents More Elusive for Stereoisomers, Patent Baristas [...]

By: Derek Lowe

Derek Lowe — Thu, 20 Sep 2007 12:54:12 +0000

I find this extremely interesting – not least because I’ve spent years making drug candidates and worry about their patentability, and also because I used to work right down the hall from Liz Smith (!)